A patient with diabetes who is receiving peritoneal dialysis is at risk for which of the following complications?

In patients with diabetes undergoing peritoneal dialysis, the correct answer is hyperglycemia. This complication arises primarily due to the glucose content of the dialysate solution used in peritoneal dialysis. Most commercial dialysate solutions contain significant amounts of glucose, which can be absorbed into the bloodstream during the dialysis process. For a patient with diabetes, especially those who may have impaired insulin secretion or action, this additional glucose load can lead to elevated blood sugar levels, resulting in hyperglycemia.

Additionally, managing blood sugar levels can be challenging for diabetic patients undergoing this treatment, as fluctuations in glucose can occur due to the absorption of glucose from the dialysis fluid. As a result, careful monitoring and management of blood glucose levels are essential in this patient population to avoid complications associated with prolonged hyperglycemia, such as increased risk of infections, cardiovascular stress, and damage to other organ systems.

In contrast, the other complications listed are less directly related to the mechanisms of peritoneal dialysis and the glucose it introduces into the body.